Literature DB >> 15908629

Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.

K N Ward1, N J Andrews, C M Verity, E Miller, E M Ross.   

Abstract

BACKGROUND: Primary human herpesvirus-6 and -7 (HHV-6/-7) infections cause febrile illness sometimes complicated by convulsions and rarely encephalopathy. AIMS: To explore the extent of such HHV-6 and -7 induced disease in young children.
METHODS: In a three year prospective study in Britain and Ireland, 205 children (2-35 months old) hospitalised with suspected encephalitis and/or severe illness with fever and convulsions were reported via the British Paediatric Surveillance Unit network. Blood samples were tested for primary HHV-6 and -7 infections.
RESULTS: 26/156 (17%) of children aged 2-23 months had primary infection (11 HHV-6; 13 HHV-7; two with both viruses) coinciding with the acute illness; this was much higher than the about three cases expected by chance. All 26 were pyrexial; 25 had convulsions (18 status epilepticus), 11 requiring ventilation. Median hospital stay was 7.5 days. For HHV-6 primary infection the median age was 53 weeks (range 42-94) and the distribution differed from that of uninfected children; for HHV-7, the median was 60 weeks (range 17-102) and the distribution did not differ for the uninfected. Fewer (5/15) children with primary HHV-7 infection had previously been infected with HHV-6 than expected.
CONCLUSIONS: Primary HHV-6 and HHV-7 infections accounted for a significant proportion of cases in those <2 years old of severe illness with fever and convulsions requiring hospital admission; each virus contributed equally. Predisposing factors are age for HHV-6 and no previous infection with HHV-6 for HHV-7. Children with such neurological disease should be investigated for primary HHV-6/-7 infections, especially in rare cases coinciding by chance with immunisation to exclude misdiagnosis as vaccine reactions.

Entities:  

Mesh:

Year:  2005        PMID: 15908629      PMCID: PMC1720457          DOI: 10.1136/adc.2004.062216

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  23 in total

1.  Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.

Authors:  K N Ward; D J Turner; X C Parada; A D Thiruchelvam
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Human herpesvirus 7.

Authors:  J B Black; P E Pellett
Journal:  Rev Med Virol       Date:  1999 Oct-Dec       Impact factor: 6.989

3.  Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children.

Authors:  M T Caserta; C B Hall; K Schnabel; C E Long; N D'Heron
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

4.  Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals.

Authors:  T Yoshikawa; S Suga; Y Asano; T Yazaki; H Kodama; T Ozaki
Journal:  Pediatrics       Date:  1989-10       Impact factor: 7.124

5.  Evaluation of the specificity and sensitivity of indirect immunofluorescence tests for IgG to human herpesviruses-6 and -7.

Authors:  K N Ward; X Couto Parada; J Passas; A D Thiruchelvam
Journal:  J Virol Methods       Date:  2002-10       Impact factor: 2.014

6.  Early diagnosis of primary human herpesvirus 6 infection in childhood: serology, polymerase chain reaction, and virus load.

Authors:  S S Chiu; C Y Cheung; C Y Tse; M Peiris
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

7.  Neuroinvasion during delayed primary HHV-7 infection in an immunocompetent adult with encephalitis and flaccid paralysis.

Authors:  K N Ward; P Kalima; K M MacLeod; T Riordan
Journal:  J Med Virol       Date:  2002-08       Impact factor: 2.327

8.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

9.  Viremia and neutralizing antibody response in infants with exanthem subitum.

Authors:  Y Asano; T Yoshikawa; S Suga; T Yazaki; T Hata; T Nagai; Y Kajita; T Ozaki; S Yoshida
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  27 in total

1.  Early developmental outcomes of children with congenital HHV-6 infection.

Authors:  Mary T Caserta; Caroline B Hall; Richard L Canfield; Philip Davidson; Gerry Lofthus; Kenneth Schnabel; Jennifer Carnahan; Lynne Shelley; Hongyue Wang
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

2.  Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Authors:  Katherine N Ward; Hoe Nam Leong; Anton D Thiruchelvam; Claire E Atkinson; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders.

Authors:  Íñigo Corral; Susana Sainz de la Maza; Mario Rodríguez; Michal-Maciej Kawiorski; María-José López-Martínez; Juan-Carlos Galán
Journal:  J Neurovirol       Date:  2018-03-13       Impact factor: 2.643

Review 4.  Clinical impact of primary infection with roseoloviruses.

Authors:  Brenda L Tesini; Leon G Epstein; Mary T Caserta
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

5.  Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Chunmei C Wang; Luis C Yepes; Robert J Danaher; Joseph R Berger; Yunanan Mootoor; Richard J Kryscio; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02

Review 6.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

7.  Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Authors:  Guy Mlechkovich; Niza Frenkel
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 8.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

9.  Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study.

Authors:  Leon G Epstein; Shlomo Shinnar; Dale C Hesdorffer; Douglas R Nordli; Aaliyah Hamidullah; Emma K T Benn; John M Pellock; L Matthew Frank; Darrell V Lewis; Solomon L Moshe; Ruth C Shinnar; Shumei Sun
Journal:  Epilepsia       Date:  2012-06-14       Impact factor: 5.864

10.  Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.

Authors:  J O Virtanen; M Färkkilä; J Multanen; L Uotila; A J Jääskeläinen; A Vaheri; M Koskiniemi
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.